Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

NCT04540081 | Completed DMC

• 1 other identifier: 1624888
• Study Type: interventional
• Target: 20,000
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

Conditions

Colon Cancer; Lung Cancer; Tobacco Use Cessation; Obesity; Pneumonia, Bacterial; Shingles; Hepatitis C

Outcome Measures

Primary Outcomes (1)

• Overall Adherence to CLOVER Metrics

  This is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for

  6 months

Secondary Outcomes (7)

• Colon cancer screening

  6 months

• Lung cancer screening

  6 months

• Tobacco cessation counseling

  6 months

• Obesity counseling

  6 months

• Pneumonia vaccination

  6 months

Study Arms (2)

CLOVER arm

EXPERIMENTAL

This arm will contain clinics that utilize the CLOVER intervention

Other: Epic Healthy Planet Population Health Module

Standard of Care arm

NO INTERVENTION

This arm will contain clinics that do not utilize the CLOVER intervention

Interventions

Epic Healthy Planet Population Health Module OTHER

Electronic population health module which is tailored to increased adherence to USPSTF and CDC recommendations

CLOVER arm

Eligibility Criteria

• Age: 50 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \- Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.

You may not qualify if:

• \- Patients outside of the age limits or have an established PCP.

Sponsors & Collaborators

• University of California, Davis: lead
• University of California, Irvine: collaborator

Study Sites (1)

UC Davis Medical Center

Sacramento, California, 95817, United States

Location

MeSH Terms

Conditions

Colonic Neoplasms; Lung Neoplasms; Tobacco Use Cessation; Obesity; Pneumonia, Bacterial; Herpes Zoster; Hepatitis C

Condition Hierarchy (Ancestors)

Colorectal Neoplasms; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms; Lung Diseases; Respiratory Tract Diseases; Health Behavior; Behavior; Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Bacterial Infections; Bacterial Infections and Mycoses; Infections; Pneumonia; Respiratory Tract Infections; Varicella Zoster Virus Infection; Herpesviridae Infections; DNA Virus Infections; Virus Diseases; Blood-Borne Infections; Communicable Diseases; Hepatitis, Viral, Human; Flaviviridae Infections; RNA Virus Infections; Hepatitis; Liver Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 31, 2020
• First Posted: September 7, 2020
• Study Start: October 5, 2020
• Primary Completion: October 5, 2022
• Study Completion: October 5, 2022
• Last Updated: December 27, 2023

Record last verified: 2021-11

Locations

US (1)